290 related articles for article (PubMed ID: 7254632)
1. [Significance of the carcinoembryonic antigen (CEA) in the diagnosis of hepatopathies].
Fiaccadori F; De Simoni M; Ghinelli F; Magnani G; Pelosi G; Salvadori C
Minerva Med; 1981 Jul; 72(28):1847-54. PubMed ID: 7254632
[TBL] [Abstract][Full Text] [Related]
2. Carcinoembryonic antigen in normal and diseased liver tissue.
Gerber MA; Thung SN
Am J Pathol; 1978 Sep; 92(3):671-9. PubMed ID: 356625
[TBL] [Abstract][Full Text] [Related]
3. [Tumor markers in focal and diffuse liver diseases].
Kasatkin IuN; Ametov AS; Mit'kov VV; Sevast'ianov SI; Zarudin VV
Med Radiol (Mosk); 1984 Apr; 29(4):39-43. PubMed ID: 6201693
[TBL] [Abstract][Full Text] [Related]
4. [Assay of the carcinoembryonic antigen (CEA) in acute and chronic liver diseases and hepatocellular carcinoma].
Piantino P; Gallo V; Pecchio F; Garlanda PF; Bonardi O
Minerva Med; 1981 Apr; 72(17):1059-64. PubMed ID: 6262678
[TBL] [Abstract][Full Text] [Related]
5. Detection of benign or malignant origin of ascites with combined indirect immunoperoxidase assays of carcinoembryonic antigen and lysozyme.
Kyrkou KA; Iatridis SG; Athanassiadou PP; Emmanouilidou AG; Athanassiadis PP
Acta Cytol; 1985; 29(1):57-62. PubMed ID: 3881880
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of the plasma levels of alpha-1 fetoprotein and carcinoembryonic antigen in chronic liver diseases and malignant neoplasias (author's transl)].
Del Vecchio-Blanco C; Caporaso N; Balzano A; Grande R
Quad Sclavo Diagn; 1977 Sep; 13(3):288-97. PubMed ID: 77537
[TBL] [Abstract][Full Text] [Related]
7. [The value of needle biopsy of the liver in the differential diagnosis of cholestatic jaundice. A clinico-pathologic study of 101 cases (author's transl)].
Kermarec J; Corallo J; Prieur J; Delmont J
Sem Hop; 1979 Jan 18-25; 55(3-4):148-58. PubMed ID: 219519
[TBL] [Abstract][Full Text] [Related]
8. [Carbohydrate antigen (CA-19-9) in the blood serum of patients with benign and malignant liver diseases].
Ametov AS; Kasatkin IuN; Mit'kov VV; Gur'eva IV
Med Radiol (Mosk); 1985 Mar; 30(3):39-41. PubMed ID: 3856723
[TBL] [Abstract][Full Text] [Related]
9. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
[TBL] [Abstract][Full Text] [Related]
10. Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen.
Novell F; Trias M; Molina R; Filella X
Anticancer Res; 1997; 17(4A):2743-6. PubMed ID: 9252708
[TBL] [Abstract][Full Text] [Related]
11. [Carcinoembryonic antigen (CEA) and non-oncological liver diseases (case report)].
Bulfoni A; Geatti O; Gobbato F; Turrin D
Arch Sci Med (Torino); 1980; 137(4):579-84. PubMed ID: 7247673
[TBL] [Abstract][Full Text] [Related]
12. [Interpretation of laparoscopic liver findings].
Belohlavek D
Fortschr Med; 1973 Jul; 91(19):816-8. PubMed ID: 4269261
[No Abstract] [Full Text] [Related]
13. Cytology of infradiaphragmatic organs. 6. Liver.
Wasastjerna C
Monogr Clin Cytol; 1979; 7():167-93. PubMed ID: 379619
[No Abstract] [Full Text] [Related]
14. [Gamma-glutamyltransferase and its significance in the diagnosis of liver diseases].
Lutz W; Szeszko A
Pol Tyg Lek; 1983 Dec; 38(50):1577-81. PubMed ID: 6146964
[No Abstract] [Full Text] [Related]
15. Carcinoembryonic antigen (CEA) in serum and bile of colorectal cancer patients with or without detectable liver metastases.
Paganuzzi M; Onetto M; de Paoli M; Castagnola M; de Salvo L; Civalleri D; Grossi CE
Anticancer Res; 1994; 14(3B):1409-12. PubMed ID: 8067714
[TBL] [Abstract][Full Text] [Related]
16. [Value of biopsy-puncture of the liver for the diagnosis of various diseases].
Lübcke P; Holzknecht R; Krause D
Cah Med; 1972 Oct; 13(11):895-900. PubMed ID: 4648444
[No Abstract] [Full Text] [Related]
17. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis.
Chen CY; Shiesh SC; Tsao HC; Lin XZ
Hepatogastroenterology; 2002; 49(45):616-20. PubMed ID: 12063953
[TBL] [Abstract][Full Text] [Related]
18. [CEA-serum levels in benign and malignant liver diseases determined using the scintigraphic camera].
Baenkler HW; Szilvási I; Wolf F
Z Gastroenterol Verh; 1976; (11):101-4. PubMed ID: 65850
[No Abstract] [Full Text] [Related]
19. [On the diagnostic value of biopsy and scintigraphy in liver diseases].
Frank H; Leodolter I; Zita G
Wien Klin Wochenschr; 1968 Aug; 80(35):648-51 passim. PubMed ID: 5678619
[No Abstract] [Full Text] [Related]
20. [Serum adenosine desaminase in liver diseases].
Zipprich B; Nilius R; Otto L; Eismann R; Busse HJ; Peters JE
Z Gesamte Inn Med; 1973 Sep; 28(18):Suppl:280-2. PubMed ID: 4766066
[No Abstract] [Full Text] [Related]
[Next] [New Search]
